ATYR
aTYR PHARMA INC
NASDAQ · Healthcare · Biotechnology · US
$0.17
−4.02%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.11
- Revenue estimate
- $2.5M
Latest reported
- Last report date
- Aug 7, 2026
- EPS actual
- -$0.11
- EPS estimate
- -$0.12
- Revenue actual
- $189.6M
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +8.6%
- Revenue beats (12Q)
- 2
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 7, 2026 | -$0.12 | -$0.11 | Beat 9.41% | $189.6M |
| May 15, 2026 | -$0.16 | -$0.11 | Beat 31.25% | — |
| Mar 5, 2026 | -$0.18 | -$0.14 | Beat 23.81% | — |
| Nov 6, 2025 | -$0.20 | -$0.26 | Miss -30.00% | $190.0K |
| Aug 7, 2025 | -$0.18 | -$0.22 | Miss -22.22% | — |
| May 7, 2025 | -$0.19 | -$0.17 | Beat 10.53% | — |
| Mar 13, 2025 | -$0.23 | -$0.18 | Beat 21.74% | — |
| Nov 7, 2024 | -$0.22 | -$0.23 | Miss -4.55% | — |
| May 2, 2024 | -$0.24 | -$0.23 | Beat 4.17% | $235.0K |
| Mar 14, 2024 | -$0.24 | -$0.25 | Miss -4.17% | — |
| Sep 29, 2023 | -$0.23 | -$0.20 | Beat 13.32% | $353.0K |
| Jun 30, 2021 | — | -$0.64 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026